{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-154219","form_type":"8-K","ticker":"BDSX","cik":"0001439725","company_name":"BIODESIX INC","filed_at":"2023-05-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.882591+00:00","generated_at":"2026-06-14T14:23:32.713030+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Biodesix stockholders elect three directors, ratify KPMG, approve option exchange at 2023 annual meeting","bullets":["All three Class III director nominees (Jean Franchi, Hany Massarany, Jack Schuler) elected with >62M votes each.","Ratification of KPMG as independent auditor for FY2023 passed: 71.4M for, 95,555 against, 28,164 abstentions.","Stock option exchange program approved: 60.4M for, 4.2M against, 19,570 abstentions, 6.9M broker non-votes.","Record date March 24, 2023; 77,979,011 shares outstanding and entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-154219","json":"https://secwatch.observer/filing/0001193125-23-154219.json","markdown":"https://secwatch.observer/filing/0001193125-23-154219.md","text":"https://secwatch.observer/filing/0001193125-23-154219.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439725/000119312523154219/0001193125-23-154219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439725/000119312523154219/d448589d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T14:23:32.713030+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a4b433ac4f76f03e8f12141d03723737125a0ce2","claim":"BIODESIX INC shareholders approved Election of three Class III director nominees to serve until the 2026 annual meeting of stockholders. at the 2023-05-23 meeting.","evidence_excerpt":"1. At the Annual Meeting, the Company’s stockholders elected, by the vote indicated below, the following three persons as the Class III directors of the Company, each to serve until the 2026 annual meeting of stockholders and until their respective successors are duly elected and qualify: Name Votes For Votes Against Abstentions Broker Non-Votes Jean Franchi 62,297,395 0 2,321,345 6,913,414 Hany Massarany 61,373,077 0 3,245,663 6,913,414 Jack Schuler 62,235,368 0 2,383,372 6,913,414","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000119312523154219/0001193125-23-154219-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-23"}],"fact_type":"shareholder_vote"},{"claim_id":"bbdfa1bb0ac714f5ea7508cbe1516c522a700326","claim":"BIODESIX INC shareholders approved Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023. at the 2023-05-23 meeting.","evidence_excerpt":"2. At the Annual Meeting, the stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023, by the vote indicated below: Votes For Votes Against Abstentions Broker Non-Votes 71,408,435 95,555 28,164 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000119312523154219/0001193125-23-154219-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-23"}],"fact_type":"shareholder_vote"},{"claim_id":"ff9795b0998f276db9432c597145f4910dce403c","claim":"BIODESIX INC shareholders approved Approval of the stock option exchange program. at the 2023-05-23 meeting.","evidence_excerpt":"3. At the Annual Meeting, the stockholders approved the stock option exchange program by the vote indicated below: Votes For Votes Against Abstentions Broker Non-Votes 60,434,183 4,164,987 19,570 6,913,414","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439725/000119312523154219/0001193125-23-154219-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-23"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}